6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
2h ago	Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
3h ago	Refers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
5h ago	The 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
12h ago	Buffalo Potash Files Annual Information Form and New Technical Report
13h ago	Ionik Announces 30-Day Extension of Senior Debt Facility

About

97,800.00KRW+3200.00 +3.38%

Closed • Updated at 16:05 GMT+00:00

Market Cap$5.05B

P/E Ratio21.96

Volume329.5K

Beta0.55

RSI48.52

Gross Margin92.62%

Health TechnologyPharmaceuticals: Major

Sk Biopharmaceuticals Co., Ltd. — investor relations, events, news, and company updates on 6ix.

Latest News

SK Life Science, Inc. to Present New Data and Epilepsy Insights at the 2026 American Academy of Neurology Annual Meeting

SK Biopharmaceuticals Expands Radiopharmaceutical Therapy Portfolio with Second In-licensed Candidate from Wisconsin Alumni Research Foundation

SK Life Science, Inc. to Present 10 Posters with New Cenobamate Data, Including a Late-Breaker, at the 2025 American Epilepsy Society (AES) Annual Meeting

New SK Life Science, Inc. Survey Reveals Communication Gaps Between Patients and Providers That Can Impact Epilepsy Care Outcomes

SK Life Science, Inc. to Host "Illuminating the Path to Added Seizure Reduction" Symposium at the 2025 American Epilepsy Society Annual Meeting

Community Chat

Ask AI